NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced the date for its annual meeting of stockholders, set for March 23, 2026.
The meeting will be held virtually, with a record date set for February 12, 2026.
Stockholders will receive notice of the meeting details and matters to be voted on in the upcoming proxy statement to be filed with the SEC.
Annual Meeting Details
The 2025 Annual Meeting of NRx Pharmaceuticals will take place on March 23, 2026, in a virtual format.
Record Date
Stockholders as of February 12, 2026, are entitled to notice and voting rights at the annual meeting.
Deadline for Proposals
Stockholder proposals or nominations must be submitted by January 26, 2026, to be considered at the 2025 Annual Meeting.
- The announcement provides clarity on the timeline and procedures for the upcoming annual meeting, ensuring transparency and adherence to corporate governance practices.
- Setting a record date allows the company to notify and involve eligible stockholders in the decision-making process, enhancing shareholder engagement.
NRx Pharmaceuticals' proactive communication regarding the 2025 Annual Meeting demonstrates commitment to shareholder engagement and transparency in corporate governance practices.